Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV001125286 | SCV001478496 | uncertain significance | Glanzmann thrombasthenia | 2024-04-16 | reviewed by expert panel | curation | The NM_000419.5(ITGA2B):c.800G>C (p.Gly267Ala) missense variant was observed by Illumina as part of a predisposition screen in an ostensibly healthy population but has not been reported in a GT patient. It occurs at the same residue as likely pathogenic variant Gly267Glu (ClinVar 953015; PM5_supporting). It is absent from population databases, including gnomADv4.0.0 (PM2_supporting) and predicted to have a deleterious effect (REVEL score 0.756; PP3).In summary there is insufficient evidence resulting in a classification of Uncertain Significance. GT-specific criteria applied: PM2_Supporting, PM5_Supporting, and PP3. |
Illumina Laboratory Services, |
RCV001125286 | SCV001284334 | uncertain significance | Glanzmann thrombasthenia | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |